COVID ‐19 antibody positivity over time and pregnancy outcomes in seven low‐and‐middle‐income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research
BJOG: An International Journal of Obstetrics & Gynaecology · 2023
DOI: 10.1111/1471-0528.17366 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2023. Verfasst von Robert L Goldenberg und 37 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Premature Birth, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
To determine COVID‐19 antibody positivity rates over time and relationships to pregnancy outcomes in low‐ and middle‐income countries (LMICs).
Design
With COVID‐19 antibody positivity at delivery as the exposure, we performed a prospective, observational cohort study in seven LMICs during the early COVID‐19 pandemic.
Setting
The study was conducted among women in the Global Network for Women's and Children's Health's Maternal and Newborn Health Registry (MNHR), a prospective, population‐based study in Kenya, Zambia, the Democratic Republic of the Congo (DRC), Bangladesh, Pakistan, India (two sites), and Guatemala. Population Pregnant women enrolled in an ongoing pregnancy registry at study sites.
Methods
From October 2020 to October 2021, standardised COVID‐19 antibody testing was performed at delivery among women enrolled in MNHR. Trained staff masked to COVID‐19 status obtained pregnancy outcomes, which were then compared with COVID‐19 antibody results. Main Outcome Measures Antibody status, stillbirth, neonatal mortality, maternal mortality and morbidity.
Results
At delivery, 26.0% of women were COVID‐19 antibody positive. Positivity increased over the four time periods across all sites: 13.8%, 15.4%, 21.0% and 40.9%. In the final period, positivity rates were: DRC 27.0%, Kenya 33.1%, Pakistan 32.8%, Guatemala 37.0%, Zambia 37.8%, Bangladesh 47.2%, Nagpur, India 57.4% and Belagavi, India 62.4%. Adjusting for site and maternal characteristics, stillbirth, neonatal mortality, low birthweight and preterm birth were not significantly associated with COVID‐19. The adjusted relative risk (aRR) for stillbirth was 1.27 (95% CI 0.95–1.69). Postpartum haemorrhage was associated with antibody positivity (aRR 1.44; 95% CI 1.01–2.07).
Conclusions
In pregnant populations in LMICs, COVID‐19 antibody positivity has increased. However, most adverse pregnancy outcomes were not significantly associated with antibody positivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Columbia University School of Medicine, New York, New York, USA.
- Aga Khan University, Karachi, Pakistan.
- International Centre for Diarrhoeal Disease Research (icddr,b), Dhaka, Bangladesh.
- University of Sydney, Sydney, New South Wales, Australia.
- RTI International, Durham, North Carolina, USA.
- Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.
ORCID-Profile: Sk Masum Billah, Manjunath Somannavar, Archana Patel, Nalini Peres-da-Silva, Elizabeth M McClure
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Goldenberg, R. L., Saleem, S., Billah, S. M., Kim, J., Moore, J. L., Ghanchi, N. K., Haque, R., Figueroa, L., Ayala, A., Lokangaka, A., Tshefu, A., Goudar, S. S., Kavi, A., Somannavar, M., Esamai, F., Mwenechanya, M., Chomba, E., Patel, A., Das, P., …, & McClure, E. M. (2023). COVID ‐19 antibody positivity over time and pregnancy outcomes in seven low‐and‐middle‐income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17366
Vancouver
Goldenberg RL, Saleem S, Billah SM, Kim J, Moore JL, Ghanchi NK, et al. COVID ‐19 antibody positivity over time and pregnancy outcomes in seven low‐and‐middle‐income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research. BJOG: An International Journal of Obstetrics & Gynaecology. 2023. doi:10.1111/1471-0528.17366
BibTeX
@article{Goldenberg2023,
author = {Goldenberg, Robert L and Saleem, Sarah and Billah, Sk Masum and Kim, Jean and Moore, Janet L and Ghanchi, Najia Karim and Haque, Rashidul and Figueroa, Lester and Ayala, Alejandra and Lokangaka, Adrien and Tshefu, Antoinette and Goudar, Shivaprasad S and Kavi, Avinash and Somannavar, Manjunath and Esamai, Fabian and Mwenechanya, Musaku and Chomba, Elwyn and Patel, Archana and Das, Prabir and Emonyi, Wilfred Injera and Edidi, Samuel and Deshmukh, Madhavi and Hossain, Biplob and Siraj, Shahjahan and Mazariegos, Manolo and Garces, Ana L and Bauserman, Melissa and Bose, Carl L and Petri, William A and Krebs, Nancy F and Derman, Richard J and Carlo, Waldemar A and Liechty, Edward A and Hibberd, Patricia L and Koso-Thomas, Marion and Peres-da-Silva, Nalini and Nolen, Tracy L and McClure, Elizabeth M},
title = {COVID ‐19 antibody positivity over time and pregnancy outcomes in seven low‐and‐middle‐income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2023},
doi = {10.1111/1471-0528.17366}
}
EUVIMED